Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GXNPC1 Injections for Chronic Stroke
NCT04088149Phase 2Completed
- Sponsor
- Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Start
- Feb 2020
- Primary completion
- Aug 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of GXNPC1 in stroke, sponsored by Gwo Xi Stem Cell Applied Technology Co., Ltd.. Started Feb 2020; status: completed.
02
Drugs
GXNPC1
03
Conditions
stroke
Beyond the preview
Go deeper on NCT04088149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04088149.